BBAI

BigBear.ai

$4.37

+5.56%
May 6, 2026
Bobby Quantitative Model
BigBear.ai Holdings, Inc. is a technology company providing mission-ready artificial intelligence (AI) and decision intelligence solutions, primarily serving defense, national security, and commercial clients. The company operates as a niche player in the AI-powered analytics space, focusing on high-consequence environments like supply chain logistics, cybersecurity, and autonomous systems. The current investor narrative is dominated by concerns over fundamental business execution, as recent news highlights a significant stock decline linked to weak revenue growth and competitive challenges, despite the company's exposure to the resilient defense sector.

People also watch

IBM

IBM

IBM

Analysis
Fiserv

Fiserv

FISV

Analysis
Cognizant

Cognizant

CTSH

Analysis
Fidelity National Information Services

Fidelity National Information Services

FIS

Analysis
Broadridge Financial Solutions

Broadridge Financial Solutions

BR

Analysis

BobbyInvestment Opinion: Should I buy BBAI Today?

Rating: Hold. The core thesis is that BBAI is a highly speculative, turnaround story with severe fundamental headwinds that currently outweigh its niche potential, making it unsuitable for most investors except those with a very high risk tolerance and a long time horizon.

Supporting evidence for this Hold rating includes: 1) A severely challenged growth profile with -37.71% YoY revenue decline, 2) Persistent unprofitability with a -48.04% Return on Equity, 3) A high and arguably unjustified valuation at 15.18x Price-to-Sales for a contracting business, and 4) Extreme market volatility as evidenced by a beta of 3.24 and a -45.83 relative strength versus the market over six months. The single analyst revenue estimate of ~$159M provides a benchmark, but without a price target, the implied upside is unclear.

The two biggest risks that would invalidate a neutral stance are: 1) Revenue contraction accelerating beyond -40% YoY, signaling a terminal business decline, and 2) A breakdown below the $2.96 support level, confirming a new downtrend phase. This Hold would upgrade to a speculative Buy only if the company demonstrates a clear quarterly inflection to positive revenue growth and expanding gross margins above 25%. It would downgrade to a Sell on a sustained break below $2.96 or a quarterly cash burn exceeding -$15M. The stock is currently overvalued relative to its deteriorating fundamentals, trading at a premium sales multiple that discounts no execution risk.

Sign up to view all

BBAI 12-Month Price Forecast

The preponderance of evidence points to a bearish stance over the next 12 months. The company's fundamental deterioration—severe revenue decline and deep cash burn—is at odds with its still-elevated sales multiple, creating a high risk of further price depreciation as the market prices in execution risk. The recent 21% monthly bounce is more characteristic of an oversold rally within a downtrend than a sustainable reversal. The stance would upgrade to neutral only upon clear, consecutive evidence of revenue stabilization and a credible plan to reduce cash burn. Confidence is medium, not high, due to the stock's extreme volatility (beta 3.24) which can produce sharp counter-trend rallies unrelated to fundamentals.

Historical Price
Current Price $4.37
Average Target $4
High Target $9.39
Low Target $2.5

Wall Street consensus

Most Wall Street analysts maintain a constructive view on BigBear.ai's 12-month outlook, with a consensus price target around $5.68 and implied upside of +30.0% versus the current price.

Average Target

$5.68

1 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

1

covering this stock

Price Range

$4 - $6

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Analyst coverage is extremely limited, with only one firm providing estimates, indicating this is a small-cap stock with minimal institutional research interest, which contributes to higher volatility and less efficient price discovery. The single analyst estimates revenue of approximately $159.2 million for the period, with a tight range between $157.0 million and $161.6 million, but no consensus price target or rating distribution is available in the provided data, underscoring the lack of broad analytical consensus. The institutional ratings history shows only two firms have been active, with HC Wainwright maintaining a 'Buy' rating while Cantor Fitzgerald downgraded from 'Overweight' to 'Neutral' in January 2026; this mixed signal and sparse coverage mean investors must rely more on independent due diligence, as the analyst community has not established a clear, confident outlook on the stock's trajectory.

Drowning in data?

Find the real signal!

Bulls vs Bears: BBAI Investment Factors

The bear case currently holds significantly stronger evidence, anchored by severe revenue contraction (-37.71% YoY), persistent cash burn (-$46.32M FCF), and a valuation (15.18x PS) that appears unsustainable given these fundamentals. The primary bull arguments—defense sector exposure and a clean balance sheet—are defensive qualities that do not yet offset the aggressive deterioration in growth and profitability. The single most important tension in the investment debate is whether the company's niche AI positioning in defense can translate into tangible, profitable growth before its cash runway expires, or if the current revenue decline is a sign of irreversible competitive erosion.

Bullish

  • Defense Sector Exposure: The company's focus on mission-ready AI for defense and national security provides a degree of revenue resilience, as these are typically long-cycle, budget-backed contracts. This niche positioning in a non-discretionary sector offers a potential buffer against broader economic downturns.
  • Low Debt Burden: With a debt-to-equity ratio of just 0.04, the company has a clean balance sheet with minimal financial leverage. This provides crucial flexibility and reduces near-term solvency risk as it navigates its current cash burn.
  • Recent Short-Term Price Rebound: The stock has surged 21.05% over the past month, showing signs of an oversold bounce from deeply depressed levels. This extreme volatility, indicated by a beta of 3.24, can work in favor of bulls during risk-on sentiment shifts.
  • Analyst Maintains Buy Rating: Despite the challenges, HC Wainwright maintains a 'Buy' rating, signaling at least one institutional voice sees a path to recovery. This provides a counter-narrative to the prevailing negative sentiment.

Bearish

  • Severe Revenue Contraction: Q4 2025 revenue of $27.3 million represents a -37.71% year-over-year decline, indicating a fundamental deterioration in the core business. This contraction, from $43.8M in Q4 2024, is a critical red flag for a growth-oriented AI company.
  • Persistent Unprofitability & Cash Burn: The company reported a net loss of -$5.83M in Q4 2025 and has a trailing twelve-month free cash flow of -$46.32M. With a gross margin of only 20.32%, it lacks the profitability to self-finance, creating a reliance on external capital.
  • Extremely High Valuation on Weak Metrics: Despite contracting sales, the stock trades at a trailing PS ratio of 15.18x, which is elevated for an unprofitable IT services company. This valuation is disconnected from fundamentals, creating significant multiple compression risk.
  • Sustained Technical Downtrend: The stock is down -40.17% over six months and trades just 40% above its 52-week low of $2.96. This price action reflects a 'falling knife' scenario with weak momentum, as confirmed by a -45.83 relative strength vs. the market over six months.

BBAI Technical Analysis

The stock is in a pronounced and sustained downtrend, evidenced by a 1-year price change of +23.95% which masks a severe recent collapse, as the 6-month price change is -40.17%. Currently trading at $4.14, the price sits just 40% above its 52-week low of $2.96, positioning it near the lower end of its annual range, which suggests the stock is being treated as a 'falling knife' with significant fundamental concerns rather than a clear value opportunity. Recent momentum shows a stark divergence, with a 1-month surge of +21.05% contrasting sharply with a 3-month decline of -17.86%; this short-term bounce likely represents a volatile, oversold rally within a broader bearish context, especially given the stock's extreme beta of 3.24, indicating it is over three times more volatile than the broader market. Key technical support is firmly established at the 52-week low of $2.96, while resistance lies at the 52-week high of $9.39; a breakdown below $2.96 would signal a new phase of capitulation, whereas any sustained move above the recent bounce highs near $4.50 is needed to suggest a potential basing pattern, though the high beta warrants caution for risk management.

Beta

3.05

3.05x market volatility

Max Drawdown

-65.9%

Largest decline past year

52-Week Range

$3-$9

Price range past year

Annual Return

+41.4%

Cumulative gain past year

PeriodBBAI ReturnS&P 500
1m+24.5%+11.4%
3m+7.1%+8.3%
6m-23.1%+9.4%
1y+41.4%+31.3%
ytd-25.2%+7.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

BBAI Fundamental Analysis

Revenue growth is severely challenged and declining, with the most recent quarterly revenue of $27.3 million representing a -37.71% year-over-year contraction; this follows a volatile pattern from the prior quarter's $33.14 million, indicating the company is struggling to achieve consistent top-line expansion in its core markets. The company is deeply unprofitable, posting a net income of -$5.83 million in Q4 2025 with a gross margin of 20.32%, which, while an improvement from the -22.86 million net income in Q2 2025, remains negative and highlights persistent margin pressure as operating expenses continue to outpace gross profit. The balance sheet and cash flow position are precarious, with a trailing twelve-month free cash flow of -$46.32 million, a return on equity of -48.04%, and a debt-to-equity ratio of 0.04; the negative free cash flow indicates the company is burning significant cash to fund operations and cannot self-finance growth, though the low debt level provides some near-term liquidity cushion against the cash burn.

Quarterly Revenue

$27300000.0B

2025-12

Revenue YoY Growth

-0.37%

YoY Comparison

Gross Margin

+0.20%

Latest Quarter

Free Cash Flow

$-46317000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Reportable Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is BBAI Overvalued?

Given the company's consistently negative net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 15.18x, while the forward-looking EV/Sales multiple is 13.49x; the modest discount on the forward multiple suggests the market anticipates only slight revenue improvement or continued challenges. Compared to typical software or IT services peers, a PS ratio above 15x is elevated, especially for a company with contracting revenue and negative margins, indicating the market may still be assigning a premium for its AI/defense niche despite fundamental weaknesses. Historically, the stock's own PS ratio has been extremely volatile, ranging from single digits to over 70x in recent quarters; the current 15.18x sits well below the extreme highs seen in 2025 but is not near historical lows, suggesting the valuation has compressed but may not yet fully reflect the deteriorating growth profile, leaving room for further multiple contraction if execution does not improve.

PE

-6.6x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -106x~256x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-7.2x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are severe and immediate. The company is burning cash at a rate of -$46.32M TTM, with revenue contracting sharply by -37.71% YoY. Its gross margin of 20.32% is too thin to cover significant operating expenses, leading to consistent net losses. While the low debt-to-equity of 0.04 provides a temporary cushion, the negative free cash flow indicates an unsustainable business model that requires external financing or a drastic operational turnaround to continue as a going concern.

Market & Competitive Risks are amplified by the stock's extreme valuation and volatility. Trading at a PS ratio of 15.18x despite contracting sales, BBAI faces high risk of multiple compression, especially if growth does not re-accelerate. Its beta of 3.24 means it is over three times more volatile than the market, magnifying downside during risk-off periods. Competitive pressures in the AI analytics space, as noted in recent news, threaten its ability to regain market share and pricing power.

The Worst-Case Scenario involves a continuation of the revenue decline, leading to accelerating cash burn and the need for a dilutive equity raise. This could trigger a loss of investor confidence, pushing the stock toward its 52-week low of $2.96. A break below this key support could lead to a capitulation sell-off. From the current price of $4.14, this scenario implies a realistic downside of approximately -29% to the 52-week low, with potential for further losses if the company's viability comes into question.

FAQ

The key risks are, in order of severity: 1) Financial Risk: The company is burning cash at an unsustainable rate (-$46.32M TTM FCF) with no clear path to profitability. 2) Operational Risk: Revenue is collapsing (-37.71% YoY), indicating potential loss of customers or competitive positioning. 3) Valuation Risk: The high PS ratio of 15.18x is vulnerable to severe compression if growth does not rebound. 4) Market Risk: With a beta of 3.24, the stock will fall dramatically more than the market during downturns, amplifying losses.

Our 12-month forecast outlines three scenarios. The Base Case (50% probability) sees the stock range-bound between $3.50 and $4.50 as the company struggles to show growth but avoids a liquidity crisis. The Bear Case (30% probability) projects a decline to between $2.50 and the 52-week low of $2.96 due to worsening fundamentals. The Bull Case (20% probability) envisions a rally to $6.50-$9.39 on successful business stabilization and new contract wins. The Base Case is most likely, predicated on the assumption that the severe revenue decline moderates but a full turnaround remains elusive.

BBAI stock appears significantly overvalued based on its current fundamentals. It trades at a Price-to-Sales ratio of 15.18x despite revenue contracting sharply. For comparison, profitable software companies often trade at similar or lower multiples while growing. This premium multiple suggests the market is still assigning value to its AI/defense narrative, but it is not justified by the deteriorating financial performance. The valuation implies an expectation of a rapid growth recovery that the company has not yet demonstrated, creating substantial downside risk if that recovery fails to materialize.

For the vast majority of investors, BBAI is not a good stock to buy at this time. The investment carries extreme risk, evidenced by a -37.71% YoY revenue decline, a -$46.32M annual cash burn, and a beta of 3.24 indicating wild price swings. It could only be considered a speculative buy by investors with a very high risk tolerance who are betting on a successful, multi-year turnaround in its defense AI business and who are prepared to lose their entire investment. The lack of analyst consensus and a recent downgrade further complicate the risk/reward assessment.

BBAI is unsuitable for short-term trading for all but the most sophisticated day traders due to its extreme volatility (beta 3.24). It is theoretically a long-term investment, but only of the highest-risk, speculative variety. Given the depth of the operational challenges, any investment should be framed with a 3-5 year horizon to allow for a potential turnaround, with the understanding that the investment could become worthless. The company pays no dividend and offers no earnings visibility, eliminating it as an income or stable growth holding. The suggested minimum holding period is irrelevant for most, as the stock is not recommended for purchase.